Global Rare Disease Drug Market Survey and Trend Research 2018

May 2018 | 96 pages | ID: G3ACB8DBE56EN
99Strategy

Abstracts

SUMMARY

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Novartis AG, Bristol-Myers Squibb Company, Celgene Corporation, F. Hoffmann-La Roche Ltd., Sanofi S.A., Sanofi S.A., Alexion Pharmaceuticals, Inc., Eli Lilly and Company, Novo Nordisk A/S, AstraZeneca, Eisai Co., Ltd., Daiichi Sankyo Company Limited, Bayer AG, GlaxoSmithKline, Merck & Co., Inc., Johnson & Johnson, Biogen, Inc., Shire, Amgen, Inc., Deciphera, Atara Biotherapeutics, ProQR etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Rare Disease Drug Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 RARE DISEASE DRUG MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

PART 4 KEY COMPANIES LIST

4.1 Novartis AG (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Bristol-Myers Squibb Company (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Celgene Corporation (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 F. Hoffmann-La Roche Ltd. (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Sanofi S.A. (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Sanofi S.A. (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Alexion Pharmaceuticals, Inc. (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Eli Lilly and Company (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Novo Nordisk A/S (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 AstraZeneca (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Eisai Co., Ltd. (Company Overview, Sales Data etc.)
4.12 Daiichi Sankyo Company Limited (Company Overview, Sales Data etc.)
4.13 Bayer AG (Company Overview, Sales Data etc.)
4.14 GlaxoSmithKline (Company Overview, Sales Data etc.)
4.15 Merck & Co., Inc. (Company Overview, Sales Data etc.)
4.16 Johnson & Johnson (Company Overview, Sales Data etc.)
4.17 Biogen, Inc. (Company Overview, Sales Data etc.)
4.18 Shire (Company Overview, Sales Data etc.)
4.19 Amgen, Inc. (Company Overview, Sales Data etc.)
4.20 Deciphera (Company Overview, Sales Data etc.)
4.21 Atara Biotherapeutics (Company Overview, Sales Data etc.)
4.22 ProQR (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Rare Disease Drug Market 2012-2017, by Type, in USD Million
Table Global Rare Disease Drug Market 2012-2017, by Type, in Volume
Table Global Rare Disease Drug Market Forecast 2018-2023, by Type, in USD Million
Table Global Rare Disease Drug Market Forecast 2018-2023, by Type, in Volume
Table Novartis AG Overview List
Table Rare Disease Drug Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Company Overview List
Table Rare Disease Drug Business Operation of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celgene Corporation Overview List
Table Rare Disease Drug Business Operation of Celgene Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table F. Hoffmann-La Roche Ltd. Overview List
Table Rare Disease Drug Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi S.A. Overview List
Table Rare Disease Drug Business Operation of Sanofi S.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi S.A. Overview List
Table Rare Disease Drug Business Operation of Sanofi S.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Alexion Pharmaceuticals, Inc. Overview List
Table Rare Disease Drug Business Operation of Alexion Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly and Company Overview List
Table Rare Disease Drug Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novo Nordisk A/S Overview List
Table Rare Disease Drug Business Operation of Novo Nordisk A/S (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Rare Disease Drug Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eisai Co., Ltd. Overview List
Table Rare Disease Drug Business Operation of Eisai Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo Company Limited Overview List
Table Rare Disease Drug Business Operation of Daiichi Sankyo Company Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer AG Overview List
Table Rare Disease Drug Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Rare Disease Drug Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co., Inc. Overview List
Table Rare Disease Drug Business Operation of Merck & Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Rare Disease Drug Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biogen, Inc. Overview List
Table Rare Disease Drug Business Operation of Biogen, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Shire Overview List
Table Rare Disease Drug Business Operation of Shire (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen, Inc. Overview List
Table Rare Disease Drug Business Operation of Amgen, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Deciphera Overview List
Table Rare Disease Drug Business Operation of Deciphera (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Atara Biotherapeutics Overview List
Table Rare Disease Drug Business Operation of Atara Biotherapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ProQR Overview List
Table Rare Disease Drug Business Operation of ProQR (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Rare Disease Drug Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Rare Disease Drug Sales Revenue Share, by Companies, in USD Million
Table Global Rare Disease Drug Sales Volume 2012-2017, by Companies, in Volume
Table Global Rare Disease Drug Sales Revenue Share, by Companies in 2017, in Volume
Table Rare Disease Drug Demand 2012-2017, by Application, in USD Million
Table Rare Disease Drug Demand 2012-2017, by Application, in Volume
Table Rare Disease Drug Demand Forecast 2018-2023, by Application, in USD Million
Table Rare Disease Drug Demand Forecast 2018-2023, by Application, in Volume
Table Global Rare Disease Drug Market 2012-2017, by Region, in USD Million
Table Global Rare Disease Drug Market 2012-2017, by Region, in Volume
Table Rare Disease Drug Market Forecast 2018-2023, by Region, in USD Million
Table Rare Disease Drug Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Rare Disease Drug Industry Chain Structure
Figure Global Rare Disease Drug Market Growth 2012-2017, by Type, in USD Million
Figure Global Rare Disease Drug Market Growth 2012-2017, by Type, in Volume
Figure Global Rare Disease Drug Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Rare Disease Drug Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region